RadNet will acquire Gleamer for up to $270 million, aiming to make DeepHealth the largest global provider of radiology clinical AI solutions.
Key Details
- 1RadNet acquires Paris-based AI firm Gleamer for up to $270 million.
- 2Gleamer serves over 700 customers across 44 countries, with FDA-cleared solutions for musculoskeletal, breast, lung, and brain imaging.
- 3The combined entity aims to become the largest provider of radiology clinical AI solutions globally.
- 4Gleamer's portfolio spans X-ray, mammography, CT, and MRI, and its products have analyzed over 30 million exams at more than 2,250 locations.
- 5Gleamer is expected to reach $30 million in annual recurring revenue in 2024, with compound annual growth over 90% from 2022–2025.
Why It Matters
This acquisition positions RadNet and its DeepHealth subsidiary as a leader in AI-driven radiology, further driving consolidation and innovation in imaging AI. The move underscores the growing demand for robust, FDA-cleared AI solutions across multiple imaging modalities.
Source
Radiology Business
Related News
•AuntMinnie
AI Model Predicts Dosimetry for Lu-177 PSMA Therapy Using PET/CT
A machine learning PET/CT model shows promise for predicting radiation dose prior to Lu-177 PSMA therapy in prostate cancer patients.
•AuntMinnie
AI Advances in Ultrasound Highlighted at AIUM 2026 Keynote
AI is increasingly enhancing ultrasound imaging, clinical workflows, and education, though challenges in trust and implementation remain.
•AuntMinnie
LLM AI Significantly Boosts MRI Accuracy For Less Experienced Readers
AI LLMs notably improve diagnostic accuracy for less experienced brain MRI readers, with diminishing benefits for experts.